Abraxane |
Albumin-bound paclitaxel nanoparticles |
Approved in 2005 |
Metastatic breast and pancreatic cancer |
Ambisome |
Liposomal amphotericin B |
Approved in 1997 |
Fungal infections |
Daunoxome |
Liposomal daunorubicin |
Approved in 1996 |
Kaposi's sarcoma |
DepoDur |
Liposomal morphine |
Approved in 2004 |
Post-surgical pain relief |
Doxil |
Liposomal doxorubicin |
Approved in 1995 |
Ovarian cancer, Kaposi's Sarcoma |
Genexol-PM |
Polymeric micelles with paclitaxel |
Available in Asian countries |
Breast and lung cancers |
Myocet |
Liposomal doxorubicin (no PEGylation) |
Available in Canada and Europe |
Metastatic breast cancer |
Neulasta |
PEG-granulocyte colony-stimulating factor(PEG-CSF) |
Approved in 2002 |
Febrile neutropenia |
Oncaspar |
PEG-L-asparaginase |
Approved in 1994 |
Lymphocytic leukemia, Non-Hodgkin's lymphoma |
PEGASYS |
PEG-interferon α2a |
Approved in 2002 |
Hepatitis C |
PEGIntron |
PEG-interferon α2b |
Approved in 2001 |
Hepatitis C |
Visudyne |
Liposomal verteporfin |
Approved in 2000 |
Age-related macular degeneration |